These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10529812)

  • 1. Curing amyloidosis: will it work in humans?
    Duff K
    Trends Neurosci; 1999 Nov; 22(11):485-6. PubMed ID: 10529812
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduced effectiveness of Abeta1-42 immunization in APP transgenic mice with significant amyloid deposition.
    Das P; Murphy MP; Younkin LH; Younkin SG; Golde TE
    Neurobiol Aging; 2001; 22(5):721-7. PubMed ID: 11705631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention and reduction of AD-type pathology in PDAPP mice immunized with A beta 1-42.
    Games D; Bard F; Grajeda H; Guido T; Khan K; Soriano F; Vasquez N; Wehner N; Johnson-Wood K; Yednock T; Seubert P; Schenk D
    Ann N Y Acad Sci; 2000; 920():274-84. PubMed ID: 11193164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is an effective immune intervention for Alzheimer's disease in prospect?
    Esiri MM
    Trends Pharmacol Sci; 2001 Jan; 22(1):2-3. PubMed ID: 11165659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcutaneous beta-amyloid immunization reduces cerebral beta-amyloid deposits without T cell infiltration and microhemorrhage.
    Nikolic WV; Bai Y; Obregon D; Hou H; Mori T; Zeng J; Ehrhart J; Shytle RD; Giunta B; Morgan D; Town T; Tan J
    Proc Natl Acad Sci U S A; 2007 Feb; 104(7):2507-12. PubMed ID: 17264212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: implications for Alzheimer's therapy.
    Soto C; Sigurdsson EM; Morelli L; Kumar RA; Castaño EM; Frangione B
    Nat Med; 1998 Jul; 4(7):822-6. PubMed ID: 9662374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HSV amplicon-mediated Abeta vaccination in Tg2576 mice: differential antigen-specific immune responses.
    Bowers WJ; Mastrangelo MA; Stanley HA; Casey AE; Milo LJ; Federoff HJ
    Neurobiol Aging; 2005 Apr; 26(4):393-407. PubMed ID: 15653168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
    Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
    Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. beta-peptide immunization: a possible new treatment for Alzheimer disease.
    Schenk DB; Seubert P; Lieberburg I; Wallace J
    Arch Neurol; 2000 Jul; 57(7):934-6. PubMed ID: 10891974
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccine efficacy of transcutaneous immunization with amyloid β using a dissolving microneedle array in a mouse model of Alzheimer's disease.
    Matsuo K; Okamoto H; Kawai Y; Quan YS; Kamiyama F; Hirobe S; Okada N; Nakagawa S
    J Neuroimmunol; 2014 Jan; 266(1-2):1-11. PubMed ID: 24315156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abeta peptide immunization restores blood-brain barrier integrity in Alzheimer disease.
    Dickstein DL; Biron KE; Ujiie M; Pfeifer CG; Jeffries AR; Jefferies WA
    FASEB J; 2006 Mar; 20(3):426-33. PubMed ID: 16507760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An attenuated immune response is sufficient to enhance cognition in an Alzheimer's disease mouse model immunized with amyloid-beta derivatives.
    Sigurdsson EM; Knudsen E; Asuni A; Fitzer-Attas C; Sage D; Quartermain D; Goni F; Frangione B; Wisniewski T
    J Neurosci; 2004 Jul; 24(28):6277-82. PubMed ID: 15254082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amyloid beta vaccination: reduced plaques and improved cognition.
    Younkin SG
    Nat Med; 2001 Jan; 7(1):18-9. PubMed ID: 11135604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of Tg-APPswe/PSEN1dE9 mice with Aβ3-10-KLH vaccine prevents synaptic deficits of Alzheimer's disease.
    Meng Y; Ding L; Zhang H; Yin W; Yan Y; Cao Y
    Behav Brain Res; 2017 Aug; 332():64-70. PubMed ID: 28577919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prophylactic Vaccine Based on Pyroglutamate-3 Amyloid β Generates Strong Antibody Response and Rescues Cognitive Decline in Alzheimer's Disease Model Mice.
    Li G; Hu ZW; Chen PG; Sun ZY; Chen YX; Zhao YF; Li YM
    ACS Chem Neurosci; 2017 Mar; 8(3):454-459. PubMed ID: 28292186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody against C-terminal Abeta selectively elevates plasma Abeta.
    Gray AJ; Sakaguchi G; Shiratori C; Becker AG; LaFrancois J; Aisen PS; Duff K; Matsuoka Y
    Neuroreport; 2007 Feb; 18(3):293-6. PubMed ID: 17314674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced Th1 and enhanced Th2 immunity after immunization with Alzheimer's beta-amyloid(1-42).
    Town T; Vendrame M; Patel A; Poetter D; DelleDonne A; Mori T; Smeed R; Crawford F; Klein T; Tan J; Mullan M
    J Neuroimmunol; 2002 Nov; 132(1-2):49-59. PubMed ID: 12417433
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin light chain, Blimp-1 and cytochrome P4501B1 peptides as potential vaccines for AL amyloidosis.
    Flies A; Ahmadi T; Parks AJ; Prokaeva T; Weng L; Rolfe SS; Seldin DC; Sherr DH
    Immunol Cell Biol; 2012 May; 90(5):528-39. PubMed ID: 21894172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EFRH-phage immunization of Alzheimer's disease animal model improves behavioral performance in Morris water maze trials.
    Lavie V; Becker M; Cohen-Kupiec R; Yacoby I; Koppel R; Wedenig M; Hutter-Paier B; Solomon B
    J Mol Neurosci; 2004; 24(1):105-13. PubMed ID: 15314258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice.
    Sigurdsson EM; Scholtzova H; Mehta PD; Frangione B; Wisniewski T
    Am J Pathol; 2001 Aug; 159(2):439-47. PubMed ID: 11485902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.